Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
6
×
life sciences
merck
6
×
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
pfizer
alzheimer's disease
bristol-myers squibb
clinical trials
deals
eli lilly
europe blog main
europe top stories
fda
glaxosmithkline
What
bio
roundup
buy
debut
drug
moves
physicians
week
acquisitions
adding
advantages
aims
alliance
annual
ash
bar
barcelona
biggest
black
brings
bristol
build
calls
cancer
ceo
changing
clinical
color
companies
company
company’s
conference
continue
crispr
daniel
days
deal
december's
decisions
diagnostic
Language
unset
6
×
Current search:
merck
×
cancer
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone